Minimally invasive transurethral ultrasound ablation provides disease control without side effects. Minimally invasive transurethral ultrasound ablation provides disease control without side effects.
Researchers at the UCLA Health Jonsson Comprehensive Cancer Center have received a five-year, $3 million grant from the National Cancer Institute to identify novel cancer biomarkers and develop AI that can detect and predict aggressive prostate cancer to help avoid unnecessary treatments and their associated negative side effects.